Brief: OliX Pharmaceuticals Says Received Notice Of Allowance From U.S. Patent And Trademark Office For OLX104C
12/08/2021 14:24
Aug 12 (Reuters) - OliX Pharmaceuticals Inc 226950.KQ :
* OLIX PHARMACEUTICALS INC - RECEIVED NOTICE OF ALLOWANCE
FROM
UNITED STATES PATENT AND TRADEMARK OFFICE FOR OLX104C
Source text for Eikon: ID:nGNX1TTQTM
Further company coverage: 226950.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OliX Pharmaceuticals
See all newsBrief: Olix Pharmaceuticals Receives Milestone Payment From L'oreal
Brief: OliX And Lilly Enter Global Licensing Agreement For Mash And Other Cardiometabolic Indications
Brief: Olix Pharmaceuticals Commences Patient Dosing In Phase 1 Clinical Trial Of Olx75016
Brief: Olix Pharmaceuticals Receives Hrec Approval To Initiate Phase 1 Clinical Trial Of Nash And Obesity Drug
Brief: OliX Pharmaceuticals Administers First Patient In Phase 1 Clinical Study of Androgenic Alopecia Treatment